Missouri's Overdose Field Report: descriptive analysis, survival trends, and naloxone dosing patterns from a community-based survey tool, 2018-2022.

IF 2.7 3区 医学 Q2 PSYCHOLOGY, CLINICAL
Zach Budesa, Kyle Vance, Ryan Smith, Ryan Carpenter, Devin Banks, Lauren Green, Brandon D L Marshall, Bruce R Schackman, Xiao Zang, Rachel Winograd
{"title":"Missouri's Overdose Field Report: descriptive analysis, survival trends, and naloxone dosing patterns from a community-based survey tool, 2018-2022.","authors":"Zach Budesa, Kyle Vance, Ryan Smith, Ryan Carpenter, Devin Banks, Lauren Green, Brandon D L Marshall, Bruce R Schackman, Xiao Zang, Rachel Winograd","doi":"10.1080/00952990.2024.2358046","DOIUrl":null,"url":null,"abstract":"<p><p><i>Background:</i> Missouri's Overdose Field Report (ODFR) is a community-based reporting system which intends to capture overdoses which may not be otherwise recorded.<i>Objectives:</i> Describe the factors related to non-fatal overdoses reported to Missouri's ODFR.<i>Methods:</i> This study used a descriptive epidemiological approach to examine the demographics and circumstances of overdoses reported to the ODFR. We used binary logistic regression to evaluate factors associated with survival and ordinal logistic regression to evaluate factors associated with number of doses used. Factors were chosen based on their relevance to overdose education and survival, and naloxone distribution.<i>Results:</i> Between 2018 and 2022, 12,225 overdoses (67% male; 78% White) were reported through the ODFR, with a 96% (n = 11,225) survival rate. Overdose survival (ps < .02) was associated with younger age (OR = .58), no opioid and stimulant co-involvement (OR = .61), and private location (OR = .48). Intramuscular naloxone in particular was associated with a significantly higher odds of survival compared to nasal naloxone (OR = 2.11). An average of 1.6 doses of naloxone per incident were administered. Additional doses were associated (ps < .02) with being older (OR = .45), female (OR = .90), nasal naloxone (versus intravenous) (OR = .65), and the belief fentanyl was present (OR = 1.49).<i>Conclusion:</i> Our reporting form provides a comprehensive picture of the events surrounding reported overdoses, including factors associated with survival, how much naloxone was used, and the effects of respondents believing fentanyl was involved. Missouri's report can provide support for current naloxone dosing, contextualize refusing post-overdose transport, and can be used to improve overdose response by community and first responders.</p>","PeriodicalId":48957,"journal":{"name":"American Journal of Drug and Alcohol Abuse","volume":" ","pages":"413-425"},"PeriodicalIF":2.7000,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11305909/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Drug and Alcohol Abuse","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00952990.2024.2358046","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/25 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Missouri's Overdose Field Report (ODFR) is a community-based reporting system which intends to capture overdoses which may not be otherwise recorded.Objectives: Describe the factors related to non-fatal overdoses reported to Missouri's ODFR.Methods: This study used a descriptive epidemiological approach to examine the demographics and circumstances of overdoses reported to the ODFR. We used binary logistic regression to evaluate factors associated with survival and ordinal logistic regression to evaluate factors associated with number of doses used. Factors were chosen based on their relevance to overdose education and survival, and naloxone distribution.Results: Between 2018 and 2022, 12,225 overdoses (67% male; 78% White) were reported through the ODFR, with a 96% (n = 11,225) survival rate. Overdose survival (ps < .02) was associated with younger age (OR = .58), no opioid and stimulant co-involvement (OR = .61), and private location (OR = .48). Intramuscular naloxone in particular was associated with a significantly higher odds of survival compared to nasal naloxone (OR = 2.11). An average of 1.6 doses of naloxone per incident were administered. Additional doses were associated (ps < .02) with being older (OR = .45), female (OR = .90), nasal naloxone (versus intravenous) (OR = .65), and the belief fentanyl was present (OR = 1.49).Conclusion: Our reporting form provides a comprehensive picture of the events surrounding reported overdoses, including factors associated with survival, how much naloxone was used, and the effects of respondents believing fentanyl was involved. Missouri's report can provide support for current naloxone dosing, contextualize refusing post-overdose transport, and can be used to improve overdose response by community and first responders.

密苏里州用药过量现场报告:2018-2022 年基于社区调查工具的描述性分析、存活趋势和纳洛酮剂量模式。
背景:密苏里州用药过量现场报告(ODFR)是一个以社区为基础的报告系统,旨在记录可能不会以其他方式记录的用药过量情况:描述向密苏里州 ODFR 报告的非致命用药过量的相关因素:本研究采用描述性流行病学方法,对向 ODFR 报告的吸毒过量的人口统计学特征和情况进行了研究。我们使用二元逻辑回归评估与存活率相关的因素,使用序数逻辑回归评估与使用剂量相关的因素。选择这些因素的依据是它们与用药过量教育和存活率以及纳洛酮分配的相关性:2018年至2022年间,ODFR报告了12225例用药过量(67%为男性;78%为白人),存活率为96%(n = 11225)。吸毒过量存活率(PS < .02)与年龄较小(OR = .58)、无阿片类药物和兴奋剂共同参与(OR = .61)和私人场所(OR = .48)有关。与鼻用纳洛酮相比,肌肉注射纳洛酮的存活几率明显更高(OR = 2.11)。每次事件平均使用 1.6 剂纳洛酮。额外剂量与年龄(OR = .45)、女性(OR = .90)、鼻腔纳洛酮(相对于静脉注射)(OR = .65)以及认为存在芬太尼(OR = 1.49)有关(PS < .02):我们的报告表提供了有关报告过量用药事件的全面信息,包括与存活率相关的因素、纳洛酮的使用量以及受访者认为芬太尼存在的影响。密苏里州的报告可以为当前的纳洛酮剂量提供支持,为拒绝药物过量后的运输提供背景资料,并可用于改善社区和急救人员对药物过量的反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.70
自引率
3.70%
发文量
68
期刊介绍: The American Journal of Drug and Alcohol Abuse (AJDAA) is an international journal published six times per year and provides an important and stimulating venue for the exchange of ideas between the researchers working in diverse areas, including public policy, epidemiology, neurobiology, and the treatment of addictive disorders. AJDAA includes a wide range of translational research, covering preclinical and clinical aspects of the field. AJDAA covers these topics with focused data presentations and authoritative reviews of timely developments in our field. Manuscripts exploring addictions other than substance use disorders are encouraged. Reviews and Perspectives of emerging fields are given priority consideration. Areas of particular interest include: public health policy; novel research methodologies; human and animal pharmacology; human translational studies, including neuroimaging; pharmacological and behavioral treatments; new modalities of care; molecular and family genetic studies; medicinal use of substances traditionally considered substances of abuse.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信